e-Article
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
Document Type
Article
Author
Jansen, Y.J.L. ; Rozeman, E.A.; Mason, R.; Goldinger, S.M.; Geukes Foppen, M.H.; Hoejberg, L.; Schmidt, H.; van Thienen, J.V.; Haanen, J.B.A.G.; Tiainen, L.; Svane, I.M.; Mäkelä, S.; Seremet, T.; Arance, A.; Dummer, R.; Bastholt, L.; Nyakas, M.; Straume, O.; Menzies, A.M.; Long, G.V.; Atkinson, V.; Blank, C.U.; Neyns, B.
Source
In Annals of Oncology July 2019 30(7):1154-1161
Subject
Language
ISSN
0923-7534